Abstract

The European Society of Cardiology working group on cardiovascular pharmacotherapy.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
EHJ - Cardiovascular Pharmacotherapy: a warm welcome to the new member of the ESC journal family.
Thomas F Lüscher
European heart journal. Cardiovascular pharmacotherapy | VOL. 1
Thomas F LüscherThomas F Lüscher
01 Jan 2015
Filling a gap in the ESC Journal Family: a warm welcome to the EHJ - Quality of Care and Clinical Outcomes.
Thomas F Lüscher
European heart journal. Quality of care & clinical outcomes | VOL. 1
Thomas F LüscherThomas F Lüscher
15 Jun 2015
Comprehensive efforts to increase adherence to statin therapy.
Alexander Vonbank ... Harald Schmidt
European heart journal | VOL. 38
Alexander Vonbank, et. al.Alexander Vonbank ... Harald Schmidt
10 Jan 2017
European Society of Cardiology Working Group on Cardiovascular Pharmacology and Drug Therapy. The chairman's report at the general assembly 2014
Keld Kjeldsen
European Heart Journal - Cardiovascular Pharmacotherapy | VOL. 1
Keld KjeldsenKeld Kjeldsen
01 Jan 2015
View more papers

More From: European heart journal

Paper Title
Journal
Date
Author
Percutaneous stellate ganglion block for electrical storm treatment: the new rising STAR?
Roberto Scacciavillani
European heart journal | VOL. -
Roberto ScacciavillaniRoberto Scacciavillani
29 May 2024
Percutaneous stellate ganglion block and catheter ablation: not enemies but allies in fighting electrical storm.
Simone Savastano ... Roberto Rordorf
European heart journal | VOL. -
Simone Savastano, et. al.Simone Savastano ... Roberto Rordorf
29 May 2024
Anticoagulation for post-operative atrial fibrillation after isolated coronary artery bypass grafting: a meta-analysis.
Mileen R D Van De Kar ... Luuk C Otterspoor
European heart journal | VOL. -
Mileen R D Van De Kar, et. al.Mileen R D Van De Kar ... Luuk C Otterspoor
29 May 2024
Great Debate: SGLT2 inhibitors should be first-line treatment in heart failure with reduced ejection fraction.
Milton Packer ... Johann Bauersachs
European heart journal | VOL. -
Milton Packer, et. al.Milton Packer ... Johann Bauersachs
28 May 2024
View more papers